PeptiMed

About:

PeptiMed is a biopharmaceutical company that develops a potent siRNA molecule to down-regulate an oncogene target to treat cancer and more.

Website: http://www.peptimed.com/

Twitter/X: search

Description:

PeptiMed is a Wisconsin-based, seed-stage biopharmaceutical company that is developing a potent siRNA molecule to down-regulate an oncogene target to treat cancer, as well as a novel nanoparticle delivery system to enable its use in animals and humans. PeptiMed was founded by repeat biotech entrepreneurs with combined 100 years of academic and corporate experience in cancer R&D.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2012-01-01

Contact Email:

Scott(AT)peptimed.com

Founders:

Nicholas Primiano, Scott Schneider

Number of Employees:

1-10

Last Funding Date:

2017-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai